SCHEMBL5388052

SCHEMBL5388052

CCCCc1c(-c2ccc(N)cc2)ccc(N)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SKP2 Q13309 1/20 0.41
CNR1 P21554 2/20 0.40
CNR2 P34972 2/20 0.40
RPS6KA3 P51812 1/20 0.36
SRC P12931 1/20 0.35
MAPT P10636 2/20 0.34
TLR8 Q9NR97 1/20 0.34
PRKCZ Q05513 1/20 0.33
RAB9A P51151 3/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP3A4 P08684 3/20 0.32
TP53 P04637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27533901 0.88 SKP2 (0.42) SKP2CNR1CNR2SRCMAPT
SCHEMBL5382796 0.85 SKP2 (0.40) SKP2CNR1CNR2SRCMAPT
SCHEMBL5379073 0.85 SKP2 (0.40) SKP2CNR1CNR2SRCMAPT
SCHEMBL5386508 0.84 RPS6KA3 (0.38) CNR1CNR2RPS6KA3MAPTPRKCZ
SCHEMBL434115 0.83 CNR1 (0.43) SKP2CNR1CNR2SRCMAPT
SCHEMBL28057457 0.82 CNR1 (0.45) SKP2CNR1CNR2SRCMAPT
SCHEMBL28869246 0.80 CNR1 (0.40) SKP2CNR1CNR2SRCMAPT
SCHEMBL28328961 0.78 SKP2 (0.37) SKP2CNR1CNR2RPS6KA3PRKCZ
SCHEMBL5379054 0.78 USP7 (0.37) SKP2CNR1CNR2RPS6KA3SRC
SCHEMBL27495210 0.78 SKP2 (0.52) SKP2SRCMAPTTLR8RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202359-B2 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2007-04-10 US disclosed
US-7084194-B2 Halogen-free resin composition CHANG CHUN PLASTICS CO., LTD. (TW) 2006-08-01 US disclosed
US-6900269-B2 Halogen-free resin composition CHANG CHUN PLASTICS CO., LTD. (TW) 2005-05-31 US disclosed
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2005-04-21 US disclosed
US-20040158023-A1 Halogen-free resin composition CHANG CHUN PLASTICS CO., LTD. (TW) 2004-08-12 US disclosed
US-20040147640-A1 Halogen-free resin composition CHANG CHUN PLASTICS CO., LTD. (TW) 2004-07-29 US disclosed
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 SKP2 2214/4885CNR1 4763/4885CNR2 4773/4885
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 SKP2 1761/4885CNR1 4792/4885CNR2 4745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.